Ravulizumab Not Yet Recruiting Phase 3 Trials for Viral Pneumonia / Novel Coronavirus Infectious Disease (COVID-19) / COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04369469Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia